<DOC>
	<DOCNO>NCT00240383</DOCNO>
	<brief_summary>A Randomized , Double-Blind , Dose-Ranging , Dose Comparison-Controlled Trial Determine Safety Efficacy BMS-298585 Subjects Type 2 Diabetes</brief_summary>
	<brief_title>Dose Ranging Study With LT , Monotherapy , PPAR</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>1 . HbA1c &gt; 7.0 % â‰¤ 10.0 % obtain Screening visit . 2 . Men woman , 1870 year age Established Type 2 diabetes 1 . Symptomatic Type 2 diabetes define marked polyuria polydipsia great 10 % weight loss last three month . 2 . Administration antihyperglycemic agent ( thiazolidinediones ) three consecutive total seven nonconsecutive day four week prior screen . 3 . Administration thiazolidinediones three consecutive total seven nonconsecutive day six week prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>